CD300LB p.Val121Ile
c.361G>A · VCV3829517
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0862 | likely benign |
|---|---|---|
| REVEL | 0.091 | moderately benign-leaning |
| SaProt | LLR -6.04 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -2.9 | GERP -3.9 |
| Regional constraint | o/e 0.88 | unconstrained · MANE · 8,609 bp · p 0.06 · regional, not allelic |
| Overall | ||
| CADD | 0.004 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.0167% | 5,990 |
| African / African-American | 0.00268% | 37,324 |
| European (non-Finnish) | 0.00204% | 49,129 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,428 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CD300LB
- Protein
- p.Val121Ile
- Coding
- c.361G>A
- MANE Select
- NM_174892
- Type
- single nucleotide variant
- Location
- chr17:74525757 (GRCh38)
- Gene constraint
- LOEUF 1.189 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 80.23
Similar variants
- CD300LB c.-14G>T Uncertain significance ★ same type
- CD300LB c.-42T>A Uncertain significance ★ same type
- CD300LB c.-59G>T Uncertain significance ★ same type
- CD300LB p.Ala26Ser Uncertain significance ★ ⚠ same type
- CD300LB p.Ala26Val Uncertain significance ★ ⚠ same type
- CD300LB p.Arg177Gly Uncertain significance ★ ⚠ same type
- CD300LB p.Arg25Thr Uncertain significance ★ ⚠ same type
- CD300LB p.Arg51Gln Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cd300lb-p-val121ile (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown